Respiratory Infections, Acute Completed Phase 4 Trials for Ingavirin (DB11944)

Also known as: Acute Respiratory Infections (ARIs) / Acute Infection Respiratory / Acute Respiratory Infections / Acute Respiratory Infection

IndicationStatusPhase
DBCOND0031056 (Respiratory Infections, Acute)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03154515Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in AdultsTreatment